Expression of CD39 and CD73 Ectonucleotidases in Interferon-γ-Treated Human Wharton's Jelly Mesenchymal Stem Cells
Research in Molecular Medicine · 19.11.2025 · 13 (4) · 259-268
DOI: 10.32598/rmm.13.4.633 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research in Molecular Medicine, online erschienen am 19.11.2025. Verfasst von Leila Pirdel und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Expression of CD39 and CD73 Ectonucleotidases in Interferon-γ-treated Human Wharton's Jelly Mesenchymal Stem CellsBackground: Mesenchymal stem cells (MSCs) exhibit substantial immunomodulatory properties.Interferon gamma (IFN-γ) exposure has been shown to enhance the immunoregulatory capacity of MSCs.This study aimed to evaluate the expression levels of ectonucleotidases CD39 and CD73, which generate adenosine, a potent immunosuppressant, in Wharton's Jelly-MSCs (WJ-MSCs) cultured in the presence or absence of IFN-γ. Materials and Methods:MSCs isolated from human umbilical cord Wharton's jelly were cultured and propagated.Phenotypic characterization of the isolated cells was performed using flow cytometry to assess the expression of characteristic surface markers.The cultured MSCs were then treated with IFN-γ.After 24 hours of treatment, the expression levels of CD39 and CD73 genes were quantified in both IFN-γ-treated and untreated cells using real-time quantitative polymerase chain reaction.
Results
Exposure to IFN-γ resulted in a significant upregulation of CD39 gene expression compared with untreated cells, while no statistically significant difference was observed in CD73 expression between IFN-γ-treated and untreated groups.
Conclusion
The findings suggest that CD39 upregulation may serve as a molecular integrator of inflammatory cytokine-mediated licensing of MSCs, contributing to their immunoregulatory capacity possibly through modulation of the expression of downstream target genes; however, further studies are required to indicate the inflammatory and immunosuppressive effects associated with CD39 induction.
Zitieren
APA
Pirdel, L., & Pirdel, M. (2025). Expression of CD39 and CD73 Ectonucleotidases in Interferon-γ-Treated Human Wharton's Jelly Mesenchymal Stem Cells. Research in Molecular Medicine, 13(4), 259-268. https://doi.org/10.32598/rmm.13.4.633
Vancouver
Pirdel L, Pirdel M. Expression of CD39 and CD73 Ectonucleotidases in Interferon-γ-Treated Human Wharton's Jelly Mesenchymal Stem Cells. Research in Molecular Medicine. 2025;13(4):259-268. doi:10.32598/rmm.13.4.633
BibTeX
@article{Pirdel2025,
author = {Pirdel, Leila and Pirdel, Manijeh},
title = {Expression of CD39 and CD73 Ectonucleotidases in Interferon-γ-Treated Human Wharton's Jelly Mesenchymal Stem Cells},
journal = {Research in Molecular Medicine},
year = {2025},
volume = {13},
number = {4},
pages = {259--268},
doi = {10.32598/rmm.13.4.633}
}
EUVIMED